1.Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis.
Haiyan SONG ; Li ZHANG ; Jielu PAN ; Lili YANG ; Guang JI
Journal of Integrative Medicine 2013;11(4):262-8
This study aims to evaluate the bioactivity of five components of the traditional Chinese medicine complex prescription Jiangzhi granules against hepatocellular steatosis.
2.Correlations between emphysema quantification and severity of chronic obstructive pulmonary disease
Pan ZHANG ; Huapeng YU ; Huizhen FAN ; Shuhan WU ; Jielu LIU ; Zekui FANG ; Chaoqun YAN
The Journal of Practical Medicine 2016;32(13):2187-2190
Objective To analyze the correlation between emphysema extent measured by high resolution computed tomography (HRCT) and pulmonary function tests, symptom score in patients with chronic obstructive pulmonary disease ( COPD ) , and to study the value of HRCT in the emphysema quantification in the clinical evaluation of COPD patients. Methods 78 patients with stable COPD were recruited to take the HRCT scan , and emphysema extent was qualified by measuring the proportion of low attenuation area in the whole lung (LAA%). Correlations between LAA% and indices of pulmonary function test, bronchial dilation test, mMRC scale, CAT score and six minutes walking distance (6MWD) were assessed. Results LAA% was negatively correlated with FEV1/FVC and DLCO%pred, and the correlation coefficients were -0.759 and -0.589 (P <0.01), respectively. LAA% was positively related to mMRC score (r = 0.342, P < 0.01), and negatively asso-ciated with 6MWD (r = -0.365,P< 0.01). There was no association between LAA% and indices of bronchodila-tion test (⊿FVC, ⊿FVC%, ⊿FEV1, ⊿FEV1%) (P > 0.05). Conclusions The severity of emphysema measured by HRCT is well correlated with the clinical symptoms , pulmonary function tests and exercise capacity in COPD patients. It can be used to diagnose emphysema early and to evaluate the severity of the disease com-prehensively. Thus, the risk factors of COPD can be controlled and the prognosis of the patients can be im-proved.
3.Advances in the clinical treatment of autoimmune hepatitis
Chao JIN ; Jielu PAN ; Xiao YU
Journal of Clinical Hepatology 2019;35(10):2331-2334
Autoimmune hepatitis (AIH) is an autoimmune-mediated chronic progressive liver inflammatory disease with unknown pathogenesis. The main purpose of AIH treatment at present is to relieve symptoms, improve liver function and pathological abnormalities, and slow down the progression to liver fibrosis. Easy recurrence and a large difference in prognosis bring difficulties to the treatment of this disease. In recent years, AIH treatment methods mainly include standard immunosuppressive therapy, substitutive therapy or second-line therapy for ineffective standard therapy, traditional Chinese medicine treatment with reduced side effects, and liver transplantation rescue therapy for end-stage AIH or severe fulminant AIH. This article reviews the above treatment methods for AIH, in order to provide a reference for clinical application.
4. Clinical analysis of 33 childhood epilepsy with occipital paroxysms
Chen CHEN ; Fei YIN ; Bo LI ; Jielu TAN ; Juan YANG ; Wenhai LI ; Xiaole WANG ; Pan PENG ; Tenghui WU ; Jing PENG
Journal of Chinese Physician 2019;21(9):1287-1291
Objective:
To investigate the clinical features of childhood epilepsy with occipital paroxysms.
Methods:
The clinical data of 33 children admitted to our hospital from 2015 to 2019 were retrospectively analyzed.
Results:
The children were divided into three groups: idiopathic group (